Atlas Trials

Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer

Clinical trial NCT02862587 · UNKNOWN

Trial details

NCT number
NCT02862587
Sponsor
Shanghai International Medical Center
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Precision CellsChemotherapyAdvanced Lung Cancer
Start date
2016-08-01
Primary completion
2018-03-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.